5 min. Read

Going Global. Khosla-AliveCor. Propeller Strategy.

In this article:

The first edition of the E&O Weekly newsletter for paying subscribers. Topics included: Going Global. Khosla-AliveCor. Propeller Strategy.

Issue 001. Going Global. Khosla-AliveCor. Propeller Strategy.

Get E&O weekly. | Subscribe
Digital health research from Brian Dolan.

Welcome to E&O.

** Wow. What a week. Thanks for the support. And, hey, if you aren't already a paying subscriber and this was forwarded your way, sign up right over here.

This is Issue 001: Let's get to it already.

Khosla owned AliveCor: This week I learned Khosla Ventures held a majority stake in AliveCor a few years back, but is now just the largest shareholder. Was that an open secret? How many other digital health companies (were at one time or) are currently mostly owned by a single investor?

Livongo S-1 research follow-up: E&O's first report focused on Glen Tullman's soon-to-IPO-company, Livongo. Readers have pointed out a few things in reaction to it: 1). Livongo seems to have sat on its acquisition of Diabeto, which could have enabled Livongo to

Paying Subscribers Only

It's a good one, too.
This digital health research is for paying Exits & Outcomes subscribers only. Subscribe now to read this article, get the weekly newsletter, and receive unrestricted access to past and future research from the Exits & Outcomes archives. Smash the link above or below to subscribe yourself -- or head over to our pricing page to subscribe your team or your whole company!

Full access to E&O's research and newsletters.

Get the subscribers-only newsletters + research reports + databases
Facebook’s RCT for AI bot Zenny. More trials
7 min. Read
FDA de novo for Google smartphone thermometer.
6 min. Read
PDT-to-virtual-clinic trend continues. HCPCS tweaks.
8 min. Read
Mahana Tinnitus. New CPT hopefuls. Better cuts salaries
6 min. Read
CMS weighs HCPCS for Natural Cycles, Leva, and Tyto. Plus: Akili Q3 results.
8 min. Read
metaMe Health seeks buyer by year-end. CMS offers up digital therapeutics nothingburger
6 min. Read
PDT Pipeline changes. Kinsa shuts down. Trials
5 min. Read
CPT decisions. Trials: Big Health, Mahana and more
6 min. Read
Akili CEO steps down. Aetna rolls back some virtual care coverage
5 min. Read
Biogen cuts digital, MedRhythms, Apple. Pfizer on PDTs.
6 min. Read
  • First
  • Previous
  • 1 of 20
  • Next
  • Last